The U.S. IPO activity looks sluggish amid the holiday-shortened week. Nevertheless, the week prior saw Texas-based cybersecurity firm SailPoint price its upsized IPO of 60M shares at a public offering ...

Global diagnostic company, Anbio Biotechnology (NNNN) priced its initial public offering of 1.6M shares at $5.00 per share.

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

The most notable insider purchases of the past week came from return buyers, including Warren Buffett. A biotech IPO also ...

Anbio Biotechnology NNNN IPO will take place February, 19 on the NASDAQ exchange under the ticker NNNN. The company is offering shares at an expected price between $5.00 and $6.00 per share with an ...

The heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public in a challenging market for ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with investor support. Explore more details here.

Cystic-fibrosis-focused Sionna Therapeutics is joining the Nasdaq this morning with an upsized public offering, while obesity ...

Proceeds will support testing of drugs designed to suppress hunger in people with the tough-to-treat rare disease and, ...

Aadvark, which will list on the Nasdaq under the ticker “AARD” Feb. 13, will have the opportunity to bring in roughly $14.1 ...

But the momentum faded, and for months, biotech stocks did not move. Few M&A transactions and initial public offerings (IPOs) ...